0.18 USD
↗ 0.00 (2.59%)AT CLOSE (03:59 PM EDT)
VolitionRx Limited
VNRXAMEX • USD
0.19
↗ 0.01 (3.58%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
0.19
↗ 0.01 (3.58%)
Market: CLOSED
VolitionRx Limited (VNRX) trades at $0.18 per share. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (81.1%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, VNRX appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 26, 2026.
Open?$0.18
High?$0.18
Low?$0.17
Prev. Close?$0.17
Volume?610.9K
Avg. Volume?2.6M
VWAP?$0.18
Rel. Volume?0.24x
Bid / Ask
Bid?$0.18 × 600
Ask?$0.19 × 1.0K
Spread?$0.01
Midpoint?$0.19
Valuation & Ratios
Market Cap?5.1M
Shares Out?18.7M
Float?22.3M
Float %?79.8%
P/E Ratio?N/A
P/B Ratio?-0.16
EPS?-$0.87
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.
Themes
Employees
75
Market Cap
5.2M
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Website
Listed
2007-04-25
Address
1489 WEST WARM SPRINGS ROAD
HENDERSON, NV 89014
Phone: 1 (512) 774-8930
HENDERSON, NV 89014
Phone: 1 (512) 774-8930
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?0
Momentum?65
Short Sent.?81
Piotroski F-Score?2/9Weak
Altman Z-Score?-53.80Distress
Confidence?46%Low
Short InterestElevated
Short % of Float?5.15%Elevated
Short Interest?1.1M
Days to Cover?1.0
Free Float22.3M
Avg Daily Volume1.7M
Settlement Date2026-10-15
Financial Health
Current Ratio?0.30Weak
Quick Ratio?0.30Weak
Cash Ratio?0.21Low
Debt/Equity?-0.34Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score92/100
P/E?N/A▾
P/B?-0.16CHEAP▾
S&P97
P/S?2.08CHEAP▾
Peers100
S&P65
P/FCF?N/A▾
EV/EBITDA?-0.7CHEAP▾
S&P97
EV/Sales?5.44FAIR▾
Peers100
S&P32
Returns & Efficiency
ROE?81.1%STRONG▾
Peers50
S&P97
ROA?-314.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-19584377
Enterprise Value?$13.4M
Fundamentals ratios updated end of day